Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera | FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine |
---|---|
Centers for Disease Control and Prevention | When vaccine is limited, who should get vaccinated first? Centers for Disease Control and Prevention |
Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U.
Centers for Disease Control and Prevention | Interim public health recommendations for vaccinated people |
---|---|
Janssen COVID-19 vaccine: Fact sheet for recipients and caregivers | Centers for Disease Control and Prevention |
Vaccination considerations for persons with underlying medication conditions.
3Centers for Disease Control and Prevention | Morbidity and Mortality Weekly Report |
---|---|
Centers for Disease Control and Prevention | Information about COVID-19 vaccines for people with allergies |